{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:36:15Z","timestamp":1740105375143,"version":"3.37.3"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019876","name":"Consumer Healthcare Products Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019876","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.yrtph.2024.105621","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T01:01:15Z","timestamp":1712797275000},"page":"105621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Safety evaluation of 8 drug degradants present in over-the-counter cough and cold medications"],"prefix":"10.1016","volume":"149","author":[{"given":"Amy L.","family":"Mihalchik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neepa Y.","family":"Choksi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy L.","family":"Roe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Wisser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kylen","family":"Whitaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Seibert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milind","family":"Deore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larisa","family":"Pavlick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele S.","family":"Wikoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.yrtph.2024.105621_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/mutage\/gey020","article-title":"Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: is aromatic N-oxide a structural alert for predicting DNA-reactive mutagenicity?","volume":"34","author":"Amberg","year":"2019","journal-title":"Mutagenesis"},{"key":"10.1016\/j.yrtph.2024.105621_bib2","article-title":"RIFM fragrance ingredient safety assessment, guaiacol, CAS Registry Number 90-05-1","volume":"165","author":"Api","year":"2022","journal-title":"Food Chem. Toxicol."},{"issue":"4","key":"10.1016\/j.yrtph.2024.105621_bib4","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1021\/cr100222q","article-title":"Mechanisms of chemical carcinogenicity and mutagenicity: a review with implications for predictive toxicology","volume":"111","author":"Benigni","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.yrtph.2024.105621_bib5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s12247-018-9366-5","article-title":"Establishing patient centric specifications for drug substance and drug product impurities","volume":"14","author":"Bercu","year":"2019","journal-title":"J Pharm Innov"},{"article-title":"Anthropometric reference data for children and adults: United States, 2011-2014","year":"2016","series-title":"Vital and Health Statistics, Series 3, Number 39. National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey (NHANES) Data","key":"10.1016\/j.yrtph.2024.105621_bib7"},{"key":"10.1016\/j.yrtph.2024.105621_bib8","unstructured":"Cold, Cough, Allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use. 21 C.F.R \u00a7 341. Updated December 22, 2023. Available at: https:\/\/www.ecfr.gov\/current\/title-21\/chapter-I\/subchapter-D\/part-341."},{"journal-title":"Substance Profile","article-title":"Guaiacol EC\/EC number: 201-964-7 | CAS number: 90-05-1","year":"2023","key":"10.1016\/j.yrtph.2024.105621_bib12"},{"year":"2023","series-title":"Appendix 1 \u2013 Hazards of Functional Groups","key":"10.1016\/j.yrtph.2024.105621_bib14"},{"issue":"147","key":"10.1016\/j.yrtph.2024.105621_bib17","volume":"71","year":"2006","journal-title":"Fed. Regist."},{"year":"2010","series-title":"FDA Guidance for Industry ANDAs: Impurities in Drug Products, U.S. Department of Health and Human Services Food and Drug Administration","key":"10.1016\/j.yrtph.2024.105621_bib18"},{"key":"10.1016\/j.yrtph.2024.105621_bib22","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0731-7085(01)00570-2","article-title":"The enantioselective determination of chlorpheniramine and its major metabolites in human plasma using chiral chromatography on a beta-cyclodextrin chiral stationary phase and mass spectrometric detection","volume":"27","author":"Fried","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"9","key":"10.1016\/j.yrtph.2024.105621_bib23","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3109\/00498258609038959","article-title":"Doxylamine metabolism in rat and monkey","volume":"16","author":"Ganes","year":"1986","journal-title":"Xenobiotica"},{"issue":"9","key":"10.1016\/j.yrtph.2024.105621_bib24","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40261-015-0311-9","article-title":"Pharmacokinetics, safety, and cardiovascular tolerability of phenylephrine HCl 10, 20, and 30 mg after a single oral administration in healthy volunteers","volume":"35","author":"Gelotte","year":"2015","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.yrtph.2024.105621_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.105023","article-title":"Calculating qualified non-mutagenic impurity levels: harmonization of approaches","volume":"126","author":"Graham","year":"2021","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"5","key":"10.1016\/j.yrtph.2024.105621_bib26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/10408444.2018.1430121","article-title":"Benchmark dose (BMD) modeling: current practice, issues, and challenges","volume":"48","author":"Haber","year":"2018","journal-title":"Crit. Rev. Toxicol."},{"issue":"3","key":"10.1016\/j.yrtph.2024.105621_bib27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0021-5198(19)30596-7","article-title":"Assessment of genotoxicity of dental antiseptics: ability of phenol, guaiacol, p-phenolsulfonic acid, sodium hypochlorite, p-chlorophenol, m-cresol or formaldehyde to induce unscheduled DNA synthesis in cultured Syrian hamster embryo cells","volume":"83","author":"Hamaguchi","year":"2000","journal-title":"Jap J Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.yrtph.2024.105621_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/em.2860050703","article-title":"Salmonella mutagenicity test results for 250 chemicals","author":"Haworth","year":"1983","journal-title":"Environ. Mutagen."},{"issue":"1","key":"10.1016\/j.yrtph.2024.105621_bib29","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1254\/jphs.FPJ04044X","article-title":"Ability of fourteen chemical agents used in dental practice to induce chromosome aberrations in Syrian hamster embryo cells","volume":"97","author":"Hikiba","year":"2005","journal-title":"J. Pharmacol. Sci."},{"issue":"18","key":"10.1016\/j.yrtph.2024.105621_bib30","first-page":"5143","article-title":"Promotion by dihydroxybenzene derivatives of N-methyl-N\u2032-nitro-N-nitrosoguanidine-induced F344 rat forestomach and glandular stomach carcinogenesis","volume":"49","author":"Hirose","year":"1989","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.yrtph.2024.105621_bib31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/bms.1200120403","article-title":"Mass spectral characterization of doxylamine and its rhesus monkey metabolites","volume":"12","author":"Holder","year":"1985","journal-title":"Biomed. Mass Spectrom."},{"issue":"3","key":"10.1016\/j.yrtph.2024.105621_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jat\/11.3.113","article-title":"Metabolism of doxylamine succinate in Fischer 344 rats. Part II: nonconjugated urinary and fecal metabolites","volume":"11","author":"Holder","year":"1987","journal-title":"J. Anal. Toxicol."},{"year":"2006","series-title":"Impurities in New Drug Products","key":"10.1016\/j.yrtph.2024.105621_bib34"},{"year":"2021","series-title":"Impurities: Guideline for Residual Solvents","key":"10.1016\/j.yrtph.2024.105621_bib35"},{"key":"10.1016\/j.yrtph.2024.105621_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/00498259109039454","article-title":"Metabolism of chlorpheniramine in rat and human by use of stable isotope","volume":"21","author":"Kasuya","year":"1991","journal-title":"Xenobiotica"},{"issue":"1","key":"10.1016\/j.yrtph.2024.105621_bib38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1349-7006.1994.tb02881.x","article-title":"Effects of combined treatment with phenolic compounds and sodium nitrite on two\u2010stage carcinogenesis and cell proliferation in the rat stomach","volume":"85","author":"Kawabe","year":"1994","journal-title":"Jap J Cancer Res"},{"issue":"4","key":"10.1016\/j.yrtph.2024.105621_bib39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2220\/biomedres.26.139","article-title":"Hydroxyl radical scavenging effects of guaiacol used in traditional dental pulp sedation: reaction kinetic study","volume":"26","author":"Mimura","year":"2005","journal-title":"Biomed. Res."},{"key":"10.1016\/j.yrtph.2024.105621_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.104895","article-title":"Harmonized 3Rs-based non-mutagenic impurity qualification study designs developed using the results of an IQ consortium survey","volume":"122","author":"Mitra","year":"2021","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.yrtph.2024.105621_bib41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10266-005-0055-8","article-title":"Ability of 13 chemical agents used in dental practice to induce sister-chromatid exchanges in Syrian hamster embryo cells","volume":"93","author":"Miyachi","year":"2005","journal-title":"Odontol"},{"key":"10.1016\/j.yrtph.2024.105621_bib42","unstructured":"NTP (National Toxicology Program). 1987. TR-322. Toxicology and Carcinogenesis Studies of Phenylephrine Hydrochloride in F344\/N Rats and B6C3F1 Mice (Feed Studies). https:\/\/ntp.niehs.nih.gov\/publications\/reports\/tr\/300s\/tr322\/index.html."},{"key":"10.1016\/j.yrtph.2024.105621_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.comtox.2017.05.003","article-title":"Navigating through the minefield of read-across tools: a review of in silico tools for grouping","volume":"3","author":"Patlewicz","year":"2017","journal-title":"Comp. Toxicol."},{"issue":"4","key":"10.1016\/j.yrtph.2024.105621_bib44","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0278-6915(82)80102-6","article-title":"Mutagenicity testing in the Salmonella typhimurium assay of phenolic compounds and phenolic fractions obtained from smokehouse smoke condensates","volume":"20","author":"Pool","year":"1982","journal-title":"Food Chem. Toxicol."},{"issue":"4","key":"10.1016\/j.yrtph.2024.105621_bib48","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4103\/2229-4708.93391","article-title":"Development and validation of stability indicating the RP-HPLC method for the estimation of related compounds of guaifenesin in pharmaceutical dosage forms","volume":"2","author":"Reddy","year":"2011","journal-title":"Pharm methods"},{"issue":"3","key":"10.1016\/j.yrtph.2024.105621_bib49","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/jat\/10.3.87","article-title":"Metabolism of 14C-labeled doxylamine succinate (Bendectin) in the rhesus monkey (Macaca mulatta)","volume":"10","author":"Slikker","year":"1986","journal-title":"J. Anal. Toxicol."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027323002400062X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027323002400062X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T02:33:54Z","timestamp":1717814034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027323002400062X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":33,"alternative-id":["S027323002400062X"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2024.105621","relation":{},"ISSN":["0273-2300"],"issn-type":[{"type":"print","value":"0273-2300"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety evaluation of 8 drug degradants present in over-the-counter cough and cold medications","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2024.105621","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105621"}}